      Español         Are                  Home                                      Herbs and                                   of this page:            as (in'' koh bot'' ue lye' num tox'' in ay'')                                 use the sharing features on this page, please enable       is this medication   should this medicine be   uses for this   special precautions should I   special dietary instructions should I   side effects can this medication   case of   other information should I                       WARNING:                           injection may spread from the area of injection and cause symptoms of botulism, including severe or life threatening difficulty breathing or swallowing.  People who develop difficulty swallowing during their treatment with this medication may continue to have this difficulty for several months.  They may need to be fed through a feeding tube to avoid getting food or drink into their lungs.  Symptoms can occur within hours of an injection with incobotulinumtoxinA or as late as several weeks after treatment.  Symptoms may occur in people of any age being treated for any condition. The risk is probably highest in children being treated for abnormal muscle tightening. Tell your doctor if you have or have ever had any swallowing problems  or breathing problems, such as asthma or emphysema, or any condition that affects your muscles or nerves such as amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease; condition in which the nerves that control muscle movement slowly die, causing the muscles to shrink and weaken), motor neuropathy (condition in which the muscles weaken over time), myasthenia gravis (condition that causes certain muscles to weaken, especially after activity), or Lambert-Eaton syndrome (condition that causes muscle weakness that may improve with activity). If you experience any of the following symptoms, call your doctor immediately: loss of strength  or muscle weakness all over the body;  double or blurred vision;  drooping eyelids;  difficulty swallowing,  breathing,  or speaking;  or inability to control urination.  doctor will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with incobotulinumtoxinA injection and each time you receive treatment. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm or the manufacturer's website to obtain the Medication         is this medication                           injection is used to relieve the symptoms of cervical dystonia (spasmodic torticollis; uncontrollable tightening of the neck muscles that may cause neck pain and abnormal head positions) in adults  and blepharospasm (uncontrollable tightening of the eyelid muscles that may cause blinking, squinting, and abnormal eyelid movements) in adults who have used onabotulinumtoxinA (Botox).  IncobotulinumtoxinA injection is in a class of medications called neurotoxins. When incobotulinumtoxinA injection is injected into a muscle, it blocks the nerve signals that cause uncontrollable tightening and movements of the         should this medicine be                           injection comes as a powder to be mixed with a liquid and injected into a muscle by a doctor. Your doctor will choose the best place to inject the medication in order to treat your condition. You may receive additional injections every 3 months, depending on your condition and on how long the effects of the treatment  doctor will probably start you on a low dose of incobotulinumtoxinA injection and gradually change your dose according to your response to the  brand or type of botulinum toxin cannot be substituted for  injection may help control your condition but will not cure it. It may take a few days or up to several weeks before you feel the full benefit of incobotulinumtoxinA         uses for this                           toxin products similar to incobotulinumtoxinA injection have been used to treat other conditions in which abnormal muscle tightening causes pain, abnormal or restricted movements, or other symptoms. These products are also sometimes used to treat excessive sweating, many types of facial wrinkles, anal fissures, and to prevent headaches in patients with chronic migraine or other types of  medication may be prescribed for other uses; ask your doctor or pharmacist for more         special precautions should I                           receiving incobotulinumtoxinA   your doctor and pharmacist if you are allergic to incobotulinumtoxinA, abobotulinumtoxinA (Dysport), onabotulinumtoxinA (Botox), rimabotulinumtoxinB (Myobloc), any other medications, or any of the ingredients in incobotulinumtoxinA injection. Ask your pharmacist or check the Medication Guide for a list of the  your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: certain antibiotics such as amikacin, clindamycin (Cleocin), colistimethate (Coly-Mycin), gentamicin, kanamycin, lincomycin (Lincocin), neomycin (Neo-Fradin, Neo-Rx), polymyxin, streptomycin, and tobramycin (Tobi); anticoagulants ('blood thinners'); cholinesterase inhibitors such as ambenonium (Mytelase), donepezil (Aricept), galantamine (Razadyne), neostigmine (Prostigmin), physostigmine, pyridostigmine (Mestinon, Regonol), rivastigmine (Exelon), and tacrine (Cognex); magnesium sulfate; medications for allergies, colds, or sleep; muscle relaxants; and quinidine. Also tell your doctor if you have received injections of any botulinum toxin product in the past four months. Your doctor may need to change the doses of your medications or monitor you carefully for side  your doctor if you have swelling or other signs of infection in the area where incobotulinumtoxinA will be injected. Your doctor will not inject the medication into an infected  your doctor if you have ever had any side effect from any botulinum toxin product or eye or face surgery and if you have or have ever had bleeding  your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while receiving incobotulinumtoxinA injection, call your  you are having surgery, including dental surgery, tell the doctor or dentist that you are receiving incobotulinumtoxinA  should know that incobotulinumtoxinA injection may cause loss of strength or muscle weakness all over the body or impaired vision. If you have any of these symptoms, do not drive a car, operate machinery, or do other dangerous  you are receiving incobotulinumtoxinA injection to treat a condition that limited your activities, talk to your doctor about increasing your activities after your treatment. Your doctor will probably want you to increase your activities gradually as your body adjusts to the effects of your          special dietary instructions should I                           your doctor tells you otherwise, continue your normal         side effects can this medication                           injection may cause side effects. Ask your doctor which side effects you are most likely to experience since some side effects may be related to (or occur more often in) the part of the body where you received the injection. Tell your doctor if any of these symptoms are severe or do not go away:    tenderness, or bruising in the place where you received the injection   tiredness  mouth  diarrhea  or muscle  eyes  blinking or effectiveness of   side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:      pain or irritation  pain  of breath  fainting  dizziness   hives   of the hands, feet, ankles, or lower   injection may cause other side effects. Call your doctor if you have any unusual problems while receiving this  you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/Safety/MedWatch or by phone         case of                           case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at  of overdose usually do not appear right after receiving the injection. If you received too much incobotulinumtoxinA or if you swallowed the medication, tell your doctor right away and also tell your doctor if you experience any of the following symptoms during the next several weeks:    weakness  moving any part of your           other information should I                           all appointments with your  your pharmacist any questions you have about incobotulinumtoxinA  is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of                                    Xeomin ®                                      BoNT-A  BTA  Toxin Type      Revised -  02/01/2011      Drugs and        Society of Health-System Pharmacists, Inc.   AHFS ® Consumer Medication Information. © Copyright, 2015. The American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland. All Rights Reserved. Duplication for commercial use must be authorized by                                                                    FAQs                                                   email                 to                 us on                                   Disclaimers           Copyright           Privacy           Accessibility                                Connect for                                National Library of         Rockville Pike, Bethesda, MD         Department of Health and Human         Institutes of                             last updated: 20 November                                                      
